Case Study

Global Biotech Improves Clinical Trial Patient Recruitment With Digital Matching

Source: Trialbee AB
cell phone data iStock-1274394138

A global biotech initiated a phase III study for severe allergic asthma. Study protocol originally accounted for enrolling 222 patients across nine UK-based investigator sites. The targeted recruitment rate for the first few months of the study was 14 patients per month, with full enrollment expected after 19 months of campaigning.

However, after deploying traditional recruitment methods, the sponsor only managed to randomize 20% of the target patient population in 11 months.

Trialbee partnered with the biotech during study start-up to get patient recruitment back on track and meet enrollment targets faster, which would not have been possible with a traditional recruitment approach.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader